HPV Vaccine for Increasing Vaccination Rates
(HPV Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the HPV vaccine treatment?
Is the HPV vaccine generally safe for humans?
How is the HPV vaccine treatment unique compared to other treatments for HPV-related conditions?
The HPV vaccine is unique because it is a preventive measure that effectively stops the transmission of HPV, which can lead to cancers, rather than treating existing infections. It is recommended for individuals aged 9 to 26 and has a strong safety profile, but it does not offer therapeutic benefits for those already infected.1112131415
What is the purpose of this trial?
Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.
Research Team
Julie HT Dang, PhD
Principal Investigator
University of California, Davis
Eligibility Criteria
This trial is for eligible patients aged 10-12 within the UC Davis Health Community Physician primary care practices, aiming to increase HPV vaccine uptake. Specific inclusion and exclusion criteria details are not provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention Implementation
Implementation of a multilevel intervention including tailored education, appointment scheduling assistance, and primary care team trainings
Follow-up
Participants are monitored for the completion of the HPV vaccine series
Treatment Details
Interventions
- HPV Vaccine
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor
National Cancer Institute (NCI)
Collaborator